Know Cancer

or
forgot password

Early Oral Feeding After a Gynaecologic Oncologic Laparotomy: A Randomized Controlled Trial


N/A
N/A
75 Years
Open (Enrolling)
Female
Female Reproductive Cancer

Thank you

Trial Information

Early Oral Feeding After a Gynaecologic Oncologic Laparotomy: A Randomized Controlled Trial


OBJECTIVES:

Primary

- To investigate the relationship between the different policies of realimentation (early
oral feedings versus traditional feedings) and the length of hospital stay following a
laparotomy in patients with gynecologic oncologic disease.

- To assess the degree of postoperative abdominal pain in these patients.

- To evaluate the incidence of ileus symptoms, including nausea and vomiting, and the
postoperative recovery of intestinal activity in these patients.

- To determine the incidence of postoperative complications in these patients.

- To elucidate the global postoperative patient's satisfaction and the quality of life in
both groups of patients.

OUTLINE: Patients are stratified according to laparotomy with or without intestinal
resection (yes vs no), and presence of ovarian cancer (yes vs no). Patients are randomized
to 1 of 2 groups at the end of surgery.

- Group 1 (early feeding): Patients are offered a liquid diet on day 1 for 24 hours
following surgery. Beginning on day 2, patients who tolerate a liquid diet are offered
a regular diet until hospital discharge.

- Group 2 (traditional feeding): Patients are offered nothing by mouth on days 1 and 2
following surgery. Beginning on day 3, patients are offered a liquid diet for 24 hours.
Beginning on day 4, patients who tolerate a liquid diet (i.e., no nausea and vomiting)
are offered a semi-solid diet for 24 hours. Beginning on day 5, patients who tolerate a
semi-solid diet are offered a light regular diet until hospital discharge.

Data is collected through the Post-Operative Pain Questionnaire, Bowel Function Table,
Global Postoperative Patient's Satisfaction Questionnaire, Postoperative Complication and
Hospital Stay Questionnaire, and the Quality of Life Questionnaires EORTC OV-28 and EORTC
QLQ-C30.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Preoperative diagnosis for probable gynecologic pathology

- No benign pathology or final histopathology diagnosis confirmed as
non-gynecologic disease

- Admitted to the European Institute of Oncology

- Elected to undergo laparotomic surgery

- No total or anterior pelvic exenteration

- No emergency laparotomy

PATIENT CHARACTERISTICS:

- No metabolic pathology (e.g., diabetes mellitus type I)

- No preoperative ASA score ≥ 4

- No preoperative infection

- No severe malnutrition (weight loss > 10% within the past 3 months)

- No preoperative intestinal obstruction

- No postoperative admission to the intensive care unit (ICU) for more than 24 hours

- No severe concomitant medical condition

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

- No prior abdominal and/or pelvis radiotherapy

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Primary Purpose: Supportive Care

Outcome Measure:

Length of hospital stay

Safety Issue:

No

Principal Investigator

Lucas Minig, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

European Institute of Oncology

Authority:

United States: Federal Government

Study ID:

CDR0000612328

NCT ID:

NCT00742677

Start Date:

January 2007

Completion Date:

Related Keywords:

  • Female Reproductive Cancer
  • female reproductive cancer

Name

Location